1.Outbreak associated with Rotavirus G11,P25 in Korea in 2018
Su-Jin CHAE ; Sunyoung JUNG ; Seung-Rye CHO ; Wooyoung CHOI ; Deog-Yong LEE
Infection and Chemotherapy 2020;52(4):616-620
We here report the first outbreak caused by rotavirus G11,P[25] in Korea in 2018, representing a case of re-assortment with pig-derived rotavirus. The genotype constellation was identical to the virus identified in Korea in 2012 as G11-P[25] -I12-R1-C1-M1-A1-N1-T1-E1-H1. The infection source was not known exactly but it must be considered infection from swine.
2.Outbreak associated with Rotavirus G11,P25 in Korea in 2018
Su-Jin CHAE ; Sunyoung JUNG ; Seung-Rye CHO ; Wooyoung CHOI ; Deog-Yong LEE
Infection and Chemotherapy 2020;52(4):616-620
We here report the first outbreak caused by rotavirus G11,P[25] in Korea in 2018, representing a case of re-assortment with pig-derived rotavirus. The genotype constellation was identical to the virus identified in Korea in 2012 as G11-P[25] -I12-R1-C1-M1-A1-N1-T1-E1-H1. The infection source was not known exactly but it must be considered infection from swine.
3.An Outbreak Associated with Sapovirus GI.3 in an Elementary School in Gyeonggi-do, Korea
Seung-Rye CHO ; Su Jung YUN ; Su-Jin CHAE ; Sunyoung JUNG ; Jong Hwa KIM ; Kum Chan YONG ; Eul Ho CHO ; Wooyoung CHOI ; Deog-Yong LEE
Journal of Korean Medical Science 2020;35(34):e281-
On October 4, 2018, an outbreak of gastroenteritis associated with sapovirus occurred among elementary school students in Gyeonggi-do, Korea. Epidemiologic studies were conducted in a retrospective cohort approach. Using self-administered questionnaires, we collected information on symptoms and food items consumed. Of the 999 subjects, 17 developed patients that met the case definition. The main symptom was vomiting (100%), and the symptomatic age was 6-12 years. Positive samples were identified by conventional reverse transcription polymerase chain reaction for sequencing. They were classified into genotype GI.3 by phylogenetic analysis. This is the first report of an outbreak associated with sapovirus GI.3 in Korea.
4.The laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients
Su-Jin CHAE ; Seung-Rye CHO ; Wooyoung CHOI ; Myung-Guk HAN ; Deog-Yong LEE
Osong Public Health and Research Perspectives 2021;12(4):269-273
The rotavirus vaccine is a live vaccine, and there is a possibility of infection by the virus strain used in the vaccine. We investigated the process of determining whether an infection was caused by the vaccine strain in a severe complex immunodeficiency (SCID) patient with rotavirus infection. The patient was vaccinated with RotaTeq prior to being diagnosed with SCID. The testing process was conducted in the following order: confirming rotavirus infection, determining its genotype, and confirming the vaccine strain. Rotavirus infection was confirmed through enzyme immunoassay and VP6 gene detection. G1 and P[8] were identified by multiplex polymerase chain reaction for the genotype, and G3 was further identified using a single primer. By detecting the fingerprint gene (WC3) of RotaTeq, it was confirmed that the detected virus was the vaccine strain. Genotypes G1 and P[8] were identified, and the infection was suspected of having been caused by rotavirus G1P[8]. G1P[8] is the most commonly detected genotype worldwide and is not included in the recombinant strains used in vaccines. Therefore, the infection was confirmed to have been caused by the vaccine strain by analyzing the genetic relationship between VP4 and VP7. Rotavirus infection by the vaccine strain can be identified through genotyping and fingerprint gene detection. However, genetic linkage analysis will also help to identify vaccine strains.
5.The laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients
Su-Jin CHAE ; Seung-Rye CHO ; Wooyoung CHOI ; Myung-Guk HAN ; Deog-Yong LEE
Osong Public Health and Research Perspectives 2021;12(4):269-273
The rotavirus vaccine is a live vaccine, and there is a possibility of infection by the virus strain used in the vaccine. We investigated the process of determining whether an infection was caused by the vaccine strain in a severe complex immunodeficiency (SCID) patient with rotavirus infection. The patient was vaccinated with RotaTeq prior to being diagnosed with SCID. The testing process was conducted in the following order: confirming rotavirus infection, determining its genotype, and confirming the vaccine strain. Rotavirus infection was confirmed through enzyme immunoassay and VP6 gene detection. G1 and P[8] were identified by multiplex polymerase chain reaction for the genotype, and G3 was further identified using a single primer. By detecting the fingerprint gene (WC3) of RotaTeq, it was confirmed that the detected virus was the vaccine strain. Genotypes G1 and P[8] were identified, and the infection was suspected of having been caused by rotavirus G1P[8]. G1P[8] is the most commonly detected genotype worldwide and is not included in the recombinant strains used in vaccines. Therefore, the infection was confirmed to have been caused by the vaccine strain by analyzing the genetic relationship between VP4 and VP7. Rotavirus infection by the vaccine strain can be identified through genotyping and fingerprint gene detection. However, genetic linkage analysis will also help to identify vaccine strains.
6.A Case Report of Left Ventricular Remodeling Surgery on End-Stage Dilated Cardiomyopathy.
Chang Young LIM ; Ju Ee KIM ; Kook Yang PARK ; Hyeon Jae LEE ; Chul Hyun PARK ; Sung Youl HYUN ; Tae Hoon AHN ; Seung Yeon HA ; Hyun I CHO ; Heum Rye PARK
The Korean Journal of Thoracic and Cardiovascular Surgery 1997;30(6):613-616
We present a case of 58-year-old female with dilated cardiomyopathy(DCMP) in whom we performed left ventricular(LV) remodeling surgery(Batista operation) to reduce the left ventricle diameter and improve left ventricular function. The patient was admitted September 1996 with heart failure NYHA class IV. There was severe orthopnea and peripheral edema. 2-D echocardiography(Echo) showed DCMP with the ejection fraction(EF) 15%, LV end diastolic dimension(LVEDD) 80mm, mitral regurgitation(MR) grade IV, tricuspid regurgitation (TR) grade II. Preoperative cardiac output(CO) was 1.5L/min and cardiac index(CI) was 1.0 L/min/m2. We proceeded with LV remodeling surgery by resection a part of LV lateral wall between both papillary muscle, from the mitral annulus to the LV apex. Size of resected LV wall was 90 x 100 x 15 mm. At the mean time, mitral valve and tricuspid valve were repaired. Postoperative 2-D Echo showed the EF 37%, LVEDD 50 mm, trivial MR, no TR. CO was 3.5L/min and CI was 2.3 L/min/m2. Her fuctional NYHA class was I.
Cardiomyopathy, Dilated*
;
Deoxycytidine Monophosphate
;
Edema
;
Female
;
Heart Failure
;
Heart Ventricles
;
Humans
;
Middle Aged
;
Mitral Valve
;
Papillary Muscles
;
Tricuspid Valve
;
Tricuspid Valve Insufficiency
;
Ventricular Function, Left
;
Ventricular Remodeling*